Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bovine vs marine chondroitin sulfate for knee osteoarthritis pain and function
2024-516337-12-00Phase 3Authorised
- Sponsor
- IBSA Group
- Start
- Aug 2025
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of chondroitin sulfate in knee osteoarthritis (OA) (2 arms), sponsored by IBSA Group. Primary endpoints: Change in average daily pain NRS at Week 24 and Change in WOMAC function subscale NRS at Week 24. Planned start Aug 2025; status: authorised.
02
Drugs
chondroitin sulfate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2024-516337-12-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516337-12-00.